Results 101 to 110 of about 4,057 (135)

Microenvironmental acidosis drives PARP- and ATM inhibitor resistance in p53 deficient pancreatic cancer. [PDF]

iScience
Ialchina R, Simonsen TR, Andersen HB, Stigliani A, Dai Y, Yao J, Larsen T, Czaplinska D, Pardo LA, Sandelin A, Pedersen SF.   +10 more
europepmc   +1 more source

Early Implementation and Clinical Outcomes of an Integrated Rheumatic Heart Disease Screening and Treatment Program in Northern Uganda. [PDF]

Circ Popul Health Outcomes
Pulle J, Kayima J, Zhang N, Danforth K, Webel AR, Oyoo CA, Longenecker CT, Sable C, Nakagaayi D, Ayaa E, Odong F, Otim IO, Rwebembera J, Sherr K, Pardo M, Atukunda M, Sarnacki R, Ogwanh R, deLoizaga S, Wirth SH, Sewankambo NK, Okello E, Beaton A, Watkins D.   +23 more
europepmc   +1 more source

Short-chain fatty acids mitigate inflammation and associated metabolic programming of human stem cell-derived enteric glial cells. [PDF]

J Neuroinflammation
Markidi A, Zaal EA, de Wit LHC, Mavrogeni ME, Caiazzo M, Kraneveld AD, Perez Pardo P, Berkers CR.   +7 more
europepmc   +1 more source

Stage III Non-small Cell Lung Cancer Resectability in a Country With Limited Diagnostic and Therapeutic Resources: A Colombian Expert Consensus. [PDF]

Cancer Control
Carvajal CA, Martínez SI, Pardo D, Padilla D, Velásquez M, Castaño W, Alvarado F, Zapata-González RA, Zuluaga J, Bruges RE, Rojas L, Zuluaga C, Viola L, Callejas AM, González-Motta A, Guerrero E, Rodríguez F, Pieschacón JR, Nicolle WG, Sánchez N, Cardona AF.   +20 more
europepmc   +1 more source

Development of antigen multimers for detection and evaluation of CAR T cells. [PDF]

Cancer Immunol Immunother
Friis RUW, Ormhøj M, Krüger-Jensen CS, Pardo CR, Halldórsdóttir HR, Barden M, Kristensen NP, Ramanathan K, Hansen MR, Abken H, Hadrup SR.   +10 more
europepmc   +1 more source

Immune Checkpoint Inhibitors and Interstitial Lung Disease: A Comprehensive Review of Pathogenesis, Diagnosis, and Management. [PDF]

Open Respir Arch
Pilia MF, Felip E, Espejo D, Pardo N, Andreu Casas M, Clofent D, Villar A, Ojanguren I.   +7 more
europepmc   +1 more source

Validation of the HER2DX genomic test in first-line advanced HER2-positive breast cancer treated with trastuzumab, pertuzumab, and taxane. [PDF]

NPJ Breast Cancer
Kubeczko M, Cobo S, Sanchez-Bayona R, Pyciński B, Soberino J, Chmielik E, Sanfeliu E, Rey M, Pardo F, Aguirre A, Castillo O, Lesniak A, Oczko-Wojciechowska M, Carcelero E, Adamo B, Vidal M, Bergamino M, Maues J, Villacampa G, Paré L, Villagrasa P, Ciruelos E, Prat A, Jarzab M, Brasó-Maristany F.   +24 more
europepmc   +1 more source

Risk Stratification and Contemporary Predictors of Survival in Hepatocellular Carcinoma Treated With Transarterial Radioembolization. [PDF]

Gastroenterology Res
Sherpally D, Das P, Tounkara F, Mumtaz K, Makary MS, Paul S, Min E, Sim AJ, Noonan A, Malalur P, Hays J, Jin N, Mittra A, Miller E, Pardo DD, Pitter K, Manne A.   +16 more
europepmc   +1 more source

A large-scale genome-wide association meta-analysis for nevus count provides direct insights into the genetics of melanoma. [PDF]

Nat Commun
Jayasinghe GJMSR, Zhu G, Pandeya N, Olsen CM, Martin NG, Lind PA, Medland SE, Gordon SD, Diaz-Torres S, Lingham G, Lee SSY, Nijsten T, Kayser M, Pardo LM, Montgomery GW, Hayward NK, Palmer JM, Hunter DJ, Han J, Hewitt AW, Falchi M, Bishop DT, Brown KM, Bataille V, Mackey DA, Iles MM, Whiteman DC, Duffy DL, MacGregor S, Law MH.   +29 more
europepmc   +1 more source

Defining Relapse and Disease Activity in Neurosarcoidosis: A Systematic Review and Proposed Framework. [PDF]

Neurol Clin Pract
Waldrop G, Dominguez Penuela SC, Barreras P, Kinder E, Fitzgerald KC, Larman HB, Pleasure SJ, Wilson MR, Stern BJ, Pardo CA, Gelfand JM.   +10 more
europepmc   +1 more source